The use of virtual reality (VR) in healthcare is a growing, seeing use in areas such as training, patient entertainment, pain management and, of course, medical imaging. The latter is the area that EchoPixel have made several breakthroughs in, and the company has now secured Series A funding.
The funding round was led by Intel Capital and also included Aurus Capital, Runa Capital and the Harris & Harris Group. This resulted in $8.5 million (USD) in funding which will be allocated to EchoPixel’s commercial, R&D and Regulatory areas.
“With its promise to make medical images more accessible to more clinicians and transform the ways doctors work and patients understand their unique anatomy, EchoPixel’s True 3D has generated excitement in the medical community,” said Sergio Aguirre, founder and Chief Executive Officer of EchoPixel.
The EchoPixel technology can be used to create life-sized VR replicas of objects and can allow doctors to move, turn, examine and even cut into virtual representations of patients.
“The growth in key centers working on significant solutions using True 3D, and the number of leadership organizations supporting EchoPixel’s marketing efforts, have positioned the company for rapid growth moving forward,” said Ron Schilling, PhD, Executive Chairman, EchoPixel.
“Intel Capital invests in pioneering technologies,” said Wendell Brooks, senior vice president of Intel Corp. and president of Intel Capital. “We are excited to invest in EchoPixel and to see their technology transform patient care through the use of augmented reality.”
VRFocus will continue to report on new developments in the VR industry.